Thanks for the reference. I probably wouldn't go as far as...

Thanks for the reference. I probably wouldn't go as far as hoping they got cancer though!

Here's the article - https://www.copyright link/rear-window/imugene-s-2-3b-valuation-raises-eyebrows-20210526-p57v8y. It was published at midnight supposedly. Some key snippets:

Headline - "Imugene’s $2.3b valuation raises eyebrows"

Some factual but seemingly negative statement on company description - "Consider an ASX biotech named Imugene. It has no revenue or products and is at the clinical trial stage, but reached an incredible $2.3 billion market-cap based on a 47¢ share price on Wednesday."

Concluding remark that seeks more information from Imugene - "This is all within the rules, but some fuller disclosure wouldn’t go amiss."

Thanks. That partially helps me understand the sudden drop.